Oxidative Stress and Cognitive Dysfunction After COVID-19 (NCT07029048) | Clinical Trial Compass
CompletedNot Applicable
Oxidative Stress and Cognitive Dysfunction After COVID-19
Kazakhstan45 participantsStarted 2021-03-01
Plain-language summary
This observational cohort study will investigate the association between oxidative stress biomarkers and post-COVID-19 cognitive impairment. A total of 45 recovered COVID-19 patients aged 30-65 will be enrolled and followed at three intervals: 0-3, 3-6, and 6-12 months post-infection. Cognitive function will be assessed using standardized memory and attention tests, while venous blood samples will be analyzed for nitric oxide, AOPP, NETs, and extracellular nucleic acids. The study aims to identify early predictors of long COVID cognitive sequelae and evaluate biological mechanisms underlying persistent neurocognitive symptoms.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age \> 18 years
* Confirmed history of COVID-19 pneumonia (PCR and CT-verified)
* Recovered and discharged from COVID-19 hospital unit
* Able to provide informed consent
* Either presence or absence of self-reported cognitive complaints
Exclusion Criteria:
* History of CNS disease (e.g., dementia, stroke, TBI)
* Psychiatric illness
* Decompensated comorbidities (diabetes, cardiovascular, renal, or hepatic failure)
* Alcohol/drug abuse
* Uncontrolled hypertension
* Acute respiratory insufficiency or fever at time of assessment
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Wechsler Memory Scale (WMS) Scores
Timeframe: Measured at 0-3, 3-6, and 6-12 months after discharge.
2
Change in Bourdon Attention Test Scores
Timeframe: Measured at 0-3, 3-6, and 6-12 months after discharge.